275 related articles for article (PubMed ID: 26788719)
21. Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines.
Pavlović J; Greenland P; Franco OH; Kavousi M; Ikram MK; Deckers JW; Ikram MA; Leening MJG
Circ Cardiovasc Qual Outcomes; 2021 Sep; 14(9):e007183. PubMed ID: 34546786
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
23. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
24. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
25. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
27. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
[TBL] [Abstract][Full Text] [Related]
28. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
[TBL] [Abstract][Full Text] [Related]
29. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
Nilsson G; Samuelsson E; Söderström L; Mooe T
BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
[TBL] [Abstract][Full Text] [Related]
30. Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease.
Djulbegovic B; Tsalatsanis A; Hozo I
J Eval Clin Pract; 2017 Apr; 23(2):241-250. PubMed ID: 26555150
[TBL] [Abstract][Full Text] [Related]
31. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
32. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
[TBL] [Abstract][Full Text] [Related]
33. Application of new cholesterol guidelines to a population-based sample.
Pencina MJ; Navar-Boggan AM; D'Agostino RB; Williams K; Neely B; Sniderman AD; Peterson ED
N Engl J Med; 2014 Apr; 370(15):1422-31. PubMed ID: 24645848
[TBL] [Abstract][Full Text] [Related]
34. The new dyslipidemia guidelines: what is the debate?
Anderson TJ; Mancini GB; Genest J; Grégoire J; Lonn EM; Hegele RA
Can J Cardiol; 2015 May; 31(5):605-12. PubMed ID: 25816728
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
[TBL] [Abstract][Full Text] [Related]
36. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
[TBL] [Abstract][Full Text] [Related]
37. Attitudes and actions: A survey to assess statin use among Finnish patients with increased risk for cardiovascular events.
Silvennoinen R; Turunen JH; Kovanen PT; Syvänne M; Tikkanen MJ
J Clin Lipidol; 2017; 11(2):485-494. PubMed ID: 28502506
[TBL] [Abstract][Full Text] [Related]
38. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
39. A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality.
Støvring H; Harmsen CG; Wisløff T; Jarbøl DE; Nexøe J; Nielsen JB; Kristiansen IS
Eur J Prev Cardiol; 2013 Oct; 20(5):827-36. PubMed ID: 22498473
[TBL] [Abstract][Full Text] [Related]
40. Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study.
Siyambalapitiya S; Bulugahapitiya U; Sithole J; Song S; Fernando DJ; Idris I
Diabetes Care; 2007 Aug; 30(8):2025-9. PubMed ID: 17519429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
